An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.
A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.
Looking beyond DNA mutations to a combination of molecular features could help determine the best drug combinations for each patient.
Michigan Medicine researchers discover how bad bacteria overtake the gut microbiome in Crohn’s disease.
How a recently identified defensive compound called itaconate tricks the bacteria behind tuberculosis.